期刊文献+

中药“连黄”对耐药沙门氏菌抑制作用的研究 被引量:10

Study on the Inhibition of the Chinese Traditional Compound Medicine "LN" to Salmonellosis
下载PDF
导出
摘要 目的:探讨中药复方"连黄"对耐药沙门氏菌的抑制作用。方法:采用琼脂平板点种培养法和药敏纸片法,研究复方中药"连黄"对耐药沙门氏菌的体外抑制作用,并进行统计学分析,判断其抑制耐药性的作用效果。结果:经中药"连黄"作用后的耐药沙门氏菌对氨基糖苷类药物的敏感性明显提高。从而表明中药复方"连黄"可有效降低沙门氏菌的耐药性。 objective: discussing the inhibition of the Chinese traditional compound medicine "LN" to the drug tolerance salmonellosis. Method: studying the inhibition of the Chinese traditional compound medicine to the salmonellosis by the way of agar plate cultivating method and drug sensitive paper disk method, and did the statistics analyze, then determined the effect of drug tolerance inhibitor. Results: the drug tolerance salmonellosis which was effected by the Chinese traditional compound medicine "LN" had high sensitivity to β-1actam. the results indicated the Chinese traditional compound medicine "LN" can reduce the drug tolerance of salmonellosis.
机构地区 延边大学农学院
出处 《吉林畜牧兽医》 2007年第9期9-11,共3页 Jilin Animal Husbandry and Veterinary Medicine
关键词 中药“连黄” 沙门氏菌 耐药性 抑制作用 the Chinese traditional compound medicine "LN" salmonellosis drug tolerance inhibition
  • 相关文献

参考文献7

二级参考文献33

  • 1雷军,王浴生,黎世能.国产氟喹诺酮药物体外耐药性研究[J].中国抗生素杂志,1993,18(3):224-228. 被引量:18
  • 2王如治.药剂学(第3版)[M].北京:人民卫生出版社,1997.125-135. 被引量:1
  • 3王如治.药剂学(第3版)[M].北京:人民卫生出版社,1997.125-135. 被引量:2
  • 4萨姆每鲁克J 弗里奇E F 曼尼阿斯T 金冬雁 黎盂枫 译.分子克隆实验指南[M].北京:科学出版社,1992.19—22,463-464. 被引量:1
  • 5Linde H J,Notka F,Metz M. et al.In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the Cterminal part of MarR[J].Antimicrob Agents Chemother, 2000,44(7): 1865-1868. 被引量:1
  • 6Markham P N. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcusaureus[J]. Antimicrob Agents Chemother, 1999,43(10) :2404-2408. 被引量:1
  • 7Dantzig A H. Reversal of Muhidrug Resistance by the P-Glycoprorein Modulator, LY335979, from the Bench to the Clinic[J]. CurtMed Chem, 2001,8(1) :39-50. 被引量:1
  • 8Garuier-suillerot A. Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action C J]. Curr Med Chem, 2001,8( 1 ) :51-64. 被引量:1
  • 9Payen L. The sulphonylurea glibenclamide inhibits muhidrug resistance protein(MRP1) activity in human lung cancer cells [J]. Br J Pharmaco1,2001,132(3) :778-784. 被引量:1
  • 10Nacsa J.The inhibition of SOS-responses and MDR by phenothiafine-metal complexes[J]. Anticancer Res, 1998, 18(4):3093-3O98. 被引量:1

共引文献262

同被引文献94

引证文献10

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部